A Radiomics-Based Model with the Potential to Differentiate Growth Hormone Deficiency and Idiopathic Short Stature on Sella MRI.

Yonsei Med J

Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, Korea.

Published: September 2022

Purpose: We hypothesized that a radiomics approach could be employed to classify children with growth hormone deficiency (GHD) and idiopathic short stature (ISS) on sella magnetic resonance imaging (MRI). Accordingly, we aimed to develop a radiomics prediction model for differentiating GHD from ISS and to evaluate the diagnostic performance thereof.

Materials And Methods: Short stature pediatric patients diagnosed with GHD or ISS from March 2011 to July 2020 at our institution were recruited. We enrolled 312 patients (GHD 210, ISS 102) with normal sella MRI and temporally split them into training and test sets (7:3). Pituitary glands were semi-automatically segmented, and 110 radiomic features were extracted from the coronal T2-weighted images. Feature selection and model development were conducted by applying mutual information (MI) and a light gradient boosting machine, respectively. After training, the model's performance was validated in the test set. We calculated mean absolute Shapley values for each of the selected input features using the Shapley additive explanations (SHAP) algorithm. Volumetric comparison was performed for GHD and ISS groups.

Results: Ten radiomic features were selected by MI. The receiver operating characteristics curve of the developed model in the test set was 0.705, with an accuracy of 70.6%. When analyzing SHAP plots, root mean squared values had the highest impact in the model, followed by various texture features. In volumetric analysis, sagittal height showed a significant difference between GHD and ISS groups.

Conclusion: Radiomic analysis of sella MRI may be able to differentiate between GHD and ISS in clinical practice for short-statured children.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424774PMC
http://dx.doi.org/10.3349/ymj.2022.63.9.856DOI Listing

Publication Analysis

Top Keywords

ghd iss
20
short stature
12
sella mri
12
growth hormone
8
hormone deficiency
8
idiopathic short
8
radiomic features
8
test set
8
ghd
7
iss
7

Similar Publications

Objective: This study aimed to determine the response to growth hormone (GH) therapy of patients with growth hormone deficiency (GHD), idiopathic short stature (ISS), and small for gestational age (SGA).

Materials And Methods: The data of the 202 children who received GH treatment were analyzed retrospectively. Laboratory parameters, puberty stages, annual growth rates, body mass index (BMI), GH side effects, target height (TH), estimated adult height (EAH), and bone age (BA) were obtained during the GH treatment period.

View Article and Find Full Text PDF

Performance of ICD-10-based injury severity scores in pediatric trauma patients using the ICD-AIS map and survival rate ratios.

J Clin Epidemiol

February 2025

Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Objectives: The performance of injury severity scores (ISSs), used widely to quantify injury severity and predict outcomes, has not been investigated in German pediatric cases. This study aims to identify the most feasible and accurate injury score predictor of mortality in German children with trauma using International Classification of Diseases 10 (ICD-10).

Study Design And Setting: Between 2014 and 2020, a retrospective observational cohort study of hospital admissions cases aged <18 years with injury-related ICD-10 codes, using the German hospital database (GHD), was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • * Most children (64.1%) were diagnosed with idiopathic short stature, and a significant number (58.9%) of those treated were male, with an average initial diagnosis age of 6.9 years.
  • * The findings emphasize the necessity for consistent monitoring of growth in all children, especially females, those from low socio-economic backgrounds, and minority groups, to ensure effective treatment options and improved adult height outcomes.
View Article and Find Full Text PDF

Background: Growth hormone deficiency (GHD) and idiopathic short stature (ISS) are the major etiologies of short stature in children. For the diagnosis of GHD and ISS, meticulous evaluations are required, including growth hormone provocation tests, which are invasive and burdensome for children. Additionally, sella magnetic resonance imaging (MRI) is necessary for assessing etiologies of GHD, which cannot evaluate hormonal secretion.

View Article and Find Full Text PDF

An analysis of acid-labile subunit (ALS) levels in children with short stature born with normal weight.

Endokrynol Pol

October 2024

Department of Paediatrics, Endocrinology, Diabetology, Metabolic Diseases, and Cardiology of Developmental Age, Pomeranian Medical University in Szczecin, Szczecin, Poland, Szczecin.

Introduction: The acid-labile subunit (ALS) is a protein best known for its function in stabilising the insulin like growth factor-1/2-insulin-like growth factor-1 binding protein 3/5 (IGF-1/2-IGFBP3/5) binary complex by creating the ternary complex and in consequence regulating the biological activity of IGF-1. The aim of the study was to assess ALS concentrations in a chosen population of children with short stature taking into account their clinical diagnosis.

Material And Methods: A total of 109 prepubertal children were involved in the study - 85 children in the study group and 24 in controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!